Markets closed the week with measured gains across major equity ETFs, even as geopolitical tensions escalated and volatility expectations rose sharply.

Free Trial: Direct Access to ValuEngine Research on over 5,000 stocks and 700 ETFs HERE ...

The results indicate that this methodology applied at the end of 2023 resulted in a strong top ten list in 2024. In a year that the Standard & Poor’s SPIVA (S&P vs. Active) blog reported that more ...

Volatility continues to define the early weeks of 2026, with markets swinging back and forth in short one-to-two day cycles. While headline indexes have struggled to establish sustained momentum, ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...